Engin Gürlevik

1.4k total citations
21 papers, 1.1k citations indexed

About

Engin Gürlevik is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Engin Gürlevik has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Immunology. Recurrent topics in Engin Gürlevik's work include Virus-based gene therapy research (9 papers), Immunotherapy and Immune Responses (6 papers) and RNA Interference and Gene Delivery (5 papers). Engin Gürlevik is often cited by papers focused on Virus-based gene therapy research (9 papers), Immunotherapy and Immune Responses (6 papers) and RNA Interference and Gene Delivery (5 papers). Engin Gürlevik collaborates with scholars based in Germany, United States and Australia. Engin Gürlevik's co-authors include Florian Kühnel, Michael P. Manns, Norman Woller, Thomas Wirth, Stefan Kubicka, Sarah Knocke, Arnold Kloos, Vera Schäffer, Marlies Eilers and Maria Sandbothe and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Engin Gürlevik

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Engin Gürlevik Germany 17 564 460 417 313 219 21 1.1k
Kiyoko Kawamura Japan 22 522 0.9× 547 1.2× 672 1.6× 244 0.8× 169 0.8× 46 1.3k
Masahiko Ishihara Japan 10 767 1.4× 575 1.3× 682 1.6× 116 0.4× 286 1.3× 24 1.4k
Linjie Guo United States 13 930 1.6× 348 0.8× 749 1.8× 248 0.8× 98 0.4× 24 1.4k
Tiangui Huang United States 12 225 0.4× 324 0.7× 133 0.3× 209 0.7× 112 0.5× 19 790
Andressa Ardiani United States 16 447 0.8× 269 0.6× 316 0.8× 148 0.5× 95 0.4× 19 819
Zao-zhong Su United States 9 335 0.6× 377 0.8× 302 0.7× 336 1.1× 67 0.3× 9 802
Joan Kyula United Kingdom 21 576 1.0× 460 1.0× 161 0.4× 443 1.4× 86 0.4× 33 1.0k
Bangxing Hong United States 18 445 0.8× 344 0.7× 578 1.4× 190 0.6× 96 0.4× 37 1.0k
Nianjun Tao United States 8 377 0.7× 539 1.2× 133 0.3× 394 1.3× 148 0.7× 12 1.1k
Alexey M. Chumakov United States 18 348 0.6× 727 1.6× 446 1.1× 165 0.5× 203 0.9× 32 1.3k

Countries citing papers authored by Engin Gürlevik

Since Specialization
Citations

This map shows the geographic impact of Engin Gürlevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engin Gürlevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engin Gürlevik more than expected).

Fields of papers citing papers by Engin Gürlevik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Engin Gürlevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engin Gürlevik. The network helps show where Engin Gürlevik may publish in the future.

Co-authorship network of co-authors of Engin Gürlevik

This figure shows the co-authorship network connecting the top 25 collaborators of Engin Gürlevik. A scholar is included among the top collaborators of Engin Gürlevik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Engin Gürlevik. Engin Gürlevik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buurman, R., Maria Sandbothe, Anke K. Bergmann, et al.. (2022). MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF. Cancer Cell International. 22(1). 192–192. 7 indexed citations
2.
Pfitzinger, Paulo L., Kun Wang, Engin Gürlevik, et al.. (2020). Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation. Journal of Experimental & Clinical Cancer Research. 39(1). 289–289. 30 indexed citations
3.
Brooks, Jennifer D., Bettina Fleischmann-Mundt, Norman Woller, et al.. (2017). Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer. Cancer Research. 78(2). 475–488. 55 indexed citations
4.
Ostroumov, Dmitrij, Sarah Knocke, Norman Woller, et al.. (2017). CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations. Cancer Research. 77(8). 1918–1926. 32 indexed citations
5.
Sandbothe, Maria, R. Buurman, Nicole Reich, et al.. (2017). The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. Journal of Hepatology. 66(5). 1012–1021. 104 indexed citations
6.
Blake, Stephen J., Kimberley Stannard, Jing Liu, et al.. (2016). Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy. Cancer Discovery. 6(4). 446–459. 187 indexed citations
7.
Woller, Norman, Engin Gürlevik, Bettina Fleischmann-Mundt, et al.. (2015). Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses. Molecular Therapy. 23(10). 1630–1640. 162 indexed citations
8.
Kloos, Arnold, Norman Woller, Engin Gürlevik, et al.. (2015). PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer. Cancer Immunology Research. 3(7). 751–763. 26 indexed citations
9.
Anggakusuma, Anne Frentzen, Engin Gürlevik, et al.. (2015). Control of Hepatitis C Virus Replication in Mouse Liver-Derived Cells by MAVS-Dependent Production of Type I and Type III Interferons. Journal of Virology. 89(7). 3833–3845. 19 indexed citations
10.
Frentzen, Anne, Anggakusuma, Engin Gürlevik, et al.. (2013). Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Hepatology. 59(1). 78–88. 34 indexed citations
11.
Gürlevik, Engin, Bettina Fleischmann-Mundt, Thomas Longerich, et al.. (2013). Adjuvant Gemcitabine Therapy Improves Survival in A Locally Induced, R0-Resectable Model of Metastatic Intrahepatic Cholangiocarcinoma. Hepatology. 58(3). 1031–1041. 31 indexed citations
12.
Gürlevik, Engin, Arnold Kloos, Norman Woller, et al.. (2013). Meganuclease-mediated Virus Self-cleavage Facilitates Tumor-specific Virus Replication. Molecular Therapy. 21(9). 1738–1748. 5 indexed citations
13.
Ostroumov, Dmitrij, Norman Woller, Engin Gürlevik, et al.. (2013). Microsphere priming facilitates induction of potent therapeutic T‐cell immune responses against autochthonous liver cancers. European Journal of Immunology. 44(4). 1213–1224. 14 indexed citations
14.
Buurman, R., Engin Gürlevik, Vera Schäffer, et al.. (2012). Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells. Gastroenterology. 143(3). 811–820.e15. 175 indexed citations
15.
Woller, Norman, Sarah Knocke, Bettina Mundt, et al.. (2011). Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. Journal of Clinical Investigation. 121(7). 2570–2582. 40 indexed citations
16.
Gürlevik, Engin, Norman Woller, Arnold Kloos, et al.. (2010). Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity. Molecular Therapy. 18(11). 1972–1982. 22 indexed citations
17.
Boozari, B, Bettina Mundt, Norman Woller, et al.. (2010). Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma. Gut. 59(10). 1416–1426. 49 indexed citations
18.
Gürlevik, Engin, Norman Woller, Nisar P. Malek, et al.. (2009). VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Gene Therapy. 16(7). 849–861. 23 indexed citations
19.
Kühnel, Florian, Engin Gürlevik, Thomas Wirth, et al.. (2009). Targeting of p53-Transcriptional Dysfunction by Conditionally Replicating Adenovirus Is Not Limited by p53-Homologues. Molecular Therapy. 18(5). 936–946. 7 indexed citations
20.
Gürlevik, Engin, Norman Woller, Thomas Wirth, et al.. (2009). p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication. Nucleic Acids Research. 37(12). e84–e84. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026